My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 169

    1.

    Prostate cancer screening: what we know and what we need to know.

    Kramer BS, Brown ML, Prorok PC, Potosky AL, Gohagan JK.

    Ann Intern Med. 1993 Nov 1;119(9):914-23.PMID: 7692780 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Screening for prostate cancer.

    Ilic D, O'Connor D, Green S, Wilt T.

    Cochrane Database Syst Rev. 2006 Jul 19;3:CD004720. Review.PMID: 16856057 [PubMed - indexed for MEDLINE]Related articles

    3.

    Benefits and harms of prostate-specific antigen screening for prostate cancer: an evidence update for the U.S. Preventive Services Task Force.

    Lin K, Lipsitz R, Miller T, Janakiraman S; U.S. Preventive Services Task Force.

    Ann Intern Med. 2008 Aug 5;149(3):192-9. Review.PMID: 18678846 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians.

    Coley CM, Barry MJ, Fleming C, Fahs MC, Mulley AG.

    Ann Intern Med. 1997 Mar 15;126(6):468-79.PMID: 9072935 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force.

    Harris R, Lohr KN.

    Ann Intern Med. 2002 Dec 3;137(11):917-29. Review.PMID: 12458993 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Detection of prostate cancer: the impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

    Schröder FH.

    Can J Urol. 2005 Feb;12 Suppl 1:2-6; discussion 92-3. Review.PMID: 15780157 [PubMed - indexed for MEDLINE]Related articles

    7.

    [Diagnosis of cancer of the prostate (I): Advancements in knowledge and practice since the consensus conference of 1989. The "Cancer of the Prostate" subcommittee of the Committee of Oncology of the French Association of Urology]

    Villers A, Grosclaude P, Haillot O, Abbou CC, Richard F, Boccon-Gibod L.

    Prog Urol. 1997 Jun;7(3):508-15. French. PMID: 9273082 [PubMed - indexed for MEDLINE]Related articles

    8.

    Comparative efficiency of prostate-specific antigen screening strategies for prostate cancer detection.

    Ross KS, Carter HB, Pearson JD, Guess HA.

    JAMA. 2000 Sep 20;284(11):1399-405.PMID: 10989402 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The socioeconomic implications of prostate-specific antigen screening.

    Benoit RM, Naslund MJ.

    Urol Clin North Am. 1997 May;24(2):451-8. Review.PMID: 9126243 [PubMed - indexed for MEDLINE]Related articles

    10.

    The economics of prostate cancer screening.

    Benoit RM, Naslund MJ.

    Oncology (Williston Park). 1997 Oct;11(10):1533-43; discussion 1543, 1547-8. Review.PMID: 9348558 [PubMed - indexed for MEDLINE]Related articles

    11.

    Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

    Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, Feuer EJ.

    J Natl Cancer Inst. 2002 Jul 3;94(13):981-90.PMID: 12096083 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    What should men know about prostate-specific antigen screening before giving informed consent?

    Chan EC, Sulmasy DP.

    Am J Med. 1998 Oct;105(4):266-74.PMID: 9809686 [PubMed - indexed for MEDLINE]Related articles

    13.

    The case for prostate cancer screening.

    Andriole GL.

    Semin Urol. 1993 May;11(2):50-3. Review.PMID: 7689738 [PubMed - indexed for MEDLINE]Related articles

    14.

    Prostate cancer and prostate-specific antigen (PSA) screening in Austria.

    Vutuc C, Schernhammer ES, Haidinger G, Waldhör T.

    Wien Klin Wochenschr. 2005 Jul;117(13-14):457-61.PMID: 16091872 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cost analyses of prostate cancer screening: frameworks for discussion. Investigators of the American Cancer Society-National Prostate Cancer Detection Project.

    Littrup PJ, Goodman AC, Mettlin CJ, Murphy GP.

    J Urol. 1994 Nov;152(5 Pt 2):1873-7.PMID: 7523734 [PubMed - indexed for MEDLINE]Related articles

    16.

    Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen.

    Krahn MD, Coombs A, Levy IG.

    CMAJ. 1999 Jan 12;160(1):49-57.PMID: 9934343 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    PSA screening: a public health dilemma.

    Mandelson MT, Wagner EH, Thompson RS.

    Annu Rev Public Health. 1995;16:283-306. Review.PMID: 7543756 [PubMed - indexed for MEDLINE]Related articles

    18.

    Comparing two modalities of screening for prostate cancer: digital rectal examination + transrectal ultrasonography vs. prostate-specific antigen.

    Ciatto S, Bonardi R, Mazzotta A, Lombardi C, Santoni R, Cardini S, Zappa M.

    Tumori. 1995 Jul-Aug;81(4):225-9.PMID: 8540115 [PubMed - indexed for MEDLINE]Related articles

    19.

    Cost analysis of screening for, diagnosing, and staging prostate cancer based on a systematic review of published studies.

    Ekwueme DU, Stroud LA, Chen Y.

    Prev Chronic Dis. 2007 Oct;4(4):A100. Epub 2007 Sep 15. Review.PMID: 17875244 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Screening for prostate cancer (PC)--an update on recent findings of the European Randomized Study of Screening for Prostate Cancer (ERSPC).

    Schröder FH.

    Urol Oncol. 2008 Sep-Oct;26(5):533-41.PMID: 18774469 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity